Zobrazeno 1 - 10
of 675
pro vyhledávání: '"Dibonaventura, M."'
Autor:
Yu SY, Fan BF, Yang F, DiBonaventura M, Chen YX, Li RY, King-Concialdi K, Kudel I, Hlavacek P, Hopps M, Udall M, Sadosky A, Cappelleri JC
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol Volume 11, Pp 539-550 (2019)
Sheng-Yuan Yu,1 Bi-Fa Fan,2 Fei Yang,1 Marco DiBonaventura,3 Yu-Xuan Chen,4 Ruo-Yu Li,5 Kristen King-Concialdi,6 Ian Kudel,6 Patrick Hlavacek,3 Markay Hopps,3 Margarita Udall,3 Alesia Sadosky,3 Joseph C Cappelleri7 1Department of Neurology, Chinese P
Externí odkaz:
https://doaj.org/article/cfe5a912e42f46e689ac1afecfbb7980
Publikováno v:
Clinical and Experimental Gastroenterology, Vol Volume 12, Pp 263-278 (2019)
Marco Boeri,1 Kelley Myers,2 Claire Ervin,2 Amy Marren,3 Marco DiBonaventura,4 Joseph C Cappelleri,5 Brett Hauber,2 David T Rubin61RTI Health Solutions, Health Preference Assessment, Belfast, BT2 8LA, UK; 2RTI Health Solutions, Health Preference Asse
Externí odkaz:
https://doaj.org/article/d50cbec3c6bf4ff49fb007f4ace2d968
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol Volume 10, Pp 457-475 (2018)
Marco DiBonaventura,1 Antonio Nicolucci,2 Henrik Meincke,3 Agathe Le Lay,3 Janine Fournier4 1Kantar Health, Health Outcomes Practice, New York, NY, USA; 2Center for Outcomes Research and Clinical Epidemiology, Pescara, Italy; 3Novo Nordisk A/S, Soebo
Externí odkaz:
https://doaj.org/article/bf59e1abc20e4062a261282356f399f8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
International Journal of COPD, Vol Volume 12, Pp 529-539 (2017)
Bo Ding,1 Marco DiBonaventura,2 Niklas Karlsson,1 Gina Bergström,1 Ulf Holmgren1 1AstraZeneca Gothenburg, Mölndal, Sweden; 2Kantar Health, New York, NY, USA Introduction: Past research has suggested significant relationships between symptoms and he
Externí odkaz:
https://doaj.org/article/44bed450e2e7492fae3af0d2bd6ac5c1
Publikováno v:
Journal of Pain Research, Vol Volume 9, Pp 967-978 (2016)
Lulu K Lee,1 Nozomi Ebata,2 Patrick Hlavacek,3 Marco DiBonaventura,4 Joseph C Cappelleri,5 Alesia Sadosky3 1Health Outcomes Practice, Kantar Health, Foster City, CA, USA; 2Neuroscience & Pain Medical Affairs, Pfizer Japan Inc., Tokyo, Japan; 3Global
Externí odkaz:
https://doaj.org/article/cfb05aedae2a430c9239fcd6c461dc06
Publikováno v:
International Journal of COPD, Vol 2016, Iss Issue 1, Pp 1139-1150 (2016)
Bo Ding,1 Marco DiBonaventura,2 Niklas Karlsson,1 Xia Ling31Department of Global Medical Affairs, AstraZeneca, Gothenburg, Sweden; 2Department of Health Outcomes Practice, Kantar Health, New York, NY, USA; 3Department of Medical Affairs China, AstraZ
Externí odkaz:
https://doaj.org/article/8a3e3f5dcd9443e8bab1010e36093015
Publikováno v:
Journal of Pain Research, Vol 2015, Iss default, Pp 119-130 (2015)
Alesia B Sadosky,1 Marco DiBonaventura,2 Joseph C Cappelleri,3 Nozomi Ebata,4 Koichi Fujii4 1Pfizer Inc, New York, NY, USA; 2Kantar Health, New York, NY, USA; 3Pfizer Inc, Groton, CT, USA; 4Pfizer Japan Inc, Tokyo, Japan Introduction: This study inve
Externí odkaz:
https://doaj.org/article/fdd51677ad8a41cda017f42c94c6109e
Publikováno v:
Patient Preference and Adherence, Vol 2014, Iss default, Pp 873-882 (2014)
Marco DiBonaventura,1 Neil Wintfeld,2 Joanna Huang,2 Amir Goren1 1Health Outcomes Practice, Kantar Health, New York, NY, 2Health Economics and Outcomes Research, Novo Nordisk, Princeton, NJ, USA Background: The main objective of this study was to inv
Externí odkaz:
https://doaj.org/article/1d38bfc36202492fb11393c45d7f2191
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol 2014, Iss default, Pp 151-163 (2014)
Samira Toghanian,1 Marco DiBonaventura,2 Krister Järbrink,1 Julie C Locklear31AstraZeneca R&D, Mölndal, Sweden; 2Kantar Health, New York, NY, USA; 3AstraZeneca Pharmaceuticals, Wilmington, DE, USABackground: Whilst studies suggest that generalized
Externí odkaz:
https://doaj.org/article/5b9513bbfa194ee18fc4248b81161a47